1. Wang, Xin, Wang, Lan-Tao, Yu, Bin. 2022. UBE2D1 and COX7C as Potential Biomarkers of Diabetes-Related Sepsis. In BioMed research international, 2022, 9463717. doi:10.1155/2022/9463717. https://pubmed.ncbi.nlm.nih.gov/35445133/
2. Wang, Yongfeng, Ma, Qianquan, Li, Haoyu, You, Jia, Liu, Dian. 2024. UBE2D1 promotes glioblastoma proliferation by modulating p21 ubiquitination. In Molecular carcinogenesis, 63, 1967-1979. doi:10.1002/mc.23786. https://pubmed.ncbi.nlm.nih.gov/39016669/
3. Critchley, William R, Smith, Gina A, Zachary, Ian C, Harrison, Michael A, Ponnambalam, Sreenivasan. 2023. The E2 ubiquitin-conjugating enzymes UBE2D1 and UBE2D2 regulate VEGFR2 dynamics and endothelial function. In Journal of cell science, 136, . doi:10.1242/jcs.260657. https://pubmed.ncbi.nlm.nih.gov/37226882/
4. Mu, Xiuli, Wei, Yuchen, Fan, Xin, Zheng, Guoxu, Yang, An-Gang. 2024. Aberrant activation of a miR-101-UBE2D1 axis contributes to the advanced progression and chemotherapy sensitivity in human hepatocellular carcinoma. In Cell death discovery, 10, 422. doi:10.1038/s41420-024-02193-y. https://pubmed.ncbi.nlm.nih.gov/39353886/
5. Hou, Liyan, Li, Yingbo, Wang, Ying, Cong, Ying, Yu, Chengyong. 2018. UBE2D1 RNA Expression Was an Independent Unfavorable Prognostic Indicator in Lung Adenocarcinoma, but Not in Lung Squamous Cell Carcinoma. In Disease markers, 2018, 4108919. doi:10.1155/2018/4108919. https://pubmed.ncbi.nlm.nih.gov/30420903/
6. Lei, Lei, Bandola-Simon, Joanna, Roche, Paul A. 2018. Ubiquitin-conjugating enzyme E2 D1 (Ube2D1) mediates lysine-independent ubiquitination of the E3 ubiquitin ligase March-I. In The Journal of biological chemistry, 293, 3904-3912. doi:10.1074/jbc.RA117.001322. https://pubmed.ncbi.nlm.nih.gov/29414787/